期刊文献+

端粒酶RNA的反义寡核苷酸抑制裸鼠移植瘤生长机制的初步探讨 被引量:2

The primary mechanism of antisense oligodeoxynucleotide targeting telomerase RNA inhibiting growth of implangted tumors in nude mice
在线阅读 下载PDF
导出
摘要 目的端粒酶是迄今为止发现的最为广谱的肿瘤标志物,端粒酶RNA的反义寡核苷酸能够抑制由A549细胞株构建的裸鼠抑制瘤的生长,本研究旨在讨论其机制。方法利用笔者前期实验获得的裸鼠抑制瘤组织,用流式细胞术检测反义寡核苷酸组(antisense oligodeoxynucleotide group,ASODN)、正义寡核苷酸组(sense oligodeoxynucleotide group,SODN)和生理盐水组(normal saline group,NS)移植瘤组织中癌细胞的凋亡指数。结果反义寡核苷酸组、正义寡核苷酸组和生理盐水组的凋亡指数分别是(23.01±2.98)%、(5.48±1.20)%和(3.11±0.93)%,反义寡核苷酸组与正义寡核苷酸组之间、反义寡核苷酸组与生理盐水组之间的差异均有显著性(P值均小于0.01),正义寡核苷酸组与生理盐水组之间的差异无显著性(P=0.056)。结论端粒酶RNA的反义寡核苷酸抑制裸鼠移植瘤生长的机制可能是通过抑制端粒酶活性后诱导癌细胞发生了凋亡。 【Objective】 Telomerase has been the most broadspecum tumor marker so far and antisense oligodeoxynucleotide targeting telomerase RNA can inhibit growth of implanted tumors in nude mice,here,we implore the mechanism. 【Methods】The apoptosis index growth of implanted tumor in Group ASODN (antisense oligodeoxynucleotide group),Group SODN (sense oligodeoxynucleotide group) and Group NS (normal saline group) were detected by flow cytometry.【Results】The apoptosis index of Group ASODN,Group SODN and Group NS was (23.01±2.98)%,(5.48±1.20)% and (3.11±0.93)%,respectively. The difference between Group ASODN and Group SODN was significant in statistics (P〈0.01),and the difference between Group ASODN and Group NS was also significant in statistics (P〈0.01),while the difference between Group SODN and Group NS was not significant in statistics (P =0.056). 【Conclusion】 The mechanism that represses the tumor growth may be that the antisense oligodeoxynucleotide induces cancer cell to apoptosis by inhibiting telomerase activity.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2010年第1期27-29,共3页 China Journal of Modern Medicine
关键词 端粒酶 反义寡核苷酸 移植瘤 凋亡 telomerase antisense oligodeoxynucleotide implanted tumor apoptosis
  • 相关文献

参考文献1

二级参考文献15

  • 1Hsu CP,Miaw J,Shai SE,et al.Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer-an adjustedmeasurement and its clinical significance.Eur J Cardiothorac Sur.2004,26:425-431.
  • 2Zaffaroni N,De Polo D,Villa R,et al.Differential expression of telomerase activity in neuroendocrine lung tumors correlation with gene product immunophenotyping.J Pathol,2003,201(1):127-133.
  • 3Fumiyuki K,Toshiaki K,Sadayuki H.Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas.Hum Pathol,2001,32(2):188-195.
  • 4Kiyoshi S,Takehiko F,Hidehisa H,et al.Increased telomerase activity and elevated hTERT mRNA expression during multistage carcinogenesis of squamous cell carcinoma of the lung.Cancer,2001,92(4):849-855.
  • 5Kondo S,Kondo Y,Li G,et al.Targeted therapy of human malignant glioma in a mouse model by 2-5A-antisense directed against telomerase RNA.Oncogene,1998,16(25):3323-3330.
  • 6Shen M,Feng YJ,Zhou XR,et al.Effects of liposome CerbB-2 antisense oligodeoxynucleotide on the human ovarian epithelial cancer transplanted subcutaneously in nude mice.Curr Adv Obstet Gynecol,1998,7(4):314-316.[沈梅,丰有吉,周先荣,等.脂质体-CerbB-2反义寡核苷酸对卵巢上皮癌裸鼠皮下移植瘤的作用,现代妇产科进展,1998,7(4):314-316.
  • 7Hiyama E,Hiyama K.Telomerase as tumor marker.Cancer Lett,2003,194(2):221-233.
  • 8Soretzki G.Telomerase inhibition as cancer therapy.Cancer Lett,2003,194(2):209-219.
  • 9Kondo Y,Koga S,Komata T,et al.Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component.Oncogene,2000,19(18):2205-2211.
  • 10Lledo S,Alfonso R,Aliii SF,et al.Antisense gene therapy using anti-k-ras and antitelomerase olignucleotides in colorectal cancer.Rev Esp Enferm Dig,2005,97(7):472-480.

共引文献4

同被引文献7

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部